Market Research - N/A, TX, US
For rare disease patients who are unable to participate in traditional clinical research, Reveles' simple integrated-technologies and decentralized clinical trial (DCT) research model enable expedited clinical trials by directly engaging patients at home. The DCT model aims to make clinical research more patient-centric: instead of all study interaction taking place at the site, a DCT brings some of those activities to the study participant's home or at an alternative location that is more convenient and safe. DCTs deploy a wide range of digital technologies to collect safety and efficacy data from study participants, normally from the comfort of the patient's own home.Reveles' operates across multiple stages of research and development, offering solutions tailored specifically for patients with rare and complex diseases for clinical trials that include: Phase II-IV, Hybrid Trials, Expanded Access Programs, and Real-World Evidence.Reveles' pharmacist-led DCT model will ensure your protocol is correctly executed to ensure GCP is followed, and timelines are met or exceeded.
DoubleClick
Outlook
Wix
Google Tag Manager
Facebook Login (Connect)
Microsoft Office 365